{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:03:05Z","timestamp":1793923385138,"version":"4.8.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2024ZD0530604"],"award-info":[{"award-number":["2024ZD0530604"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFA1800804"],"award-info":[{"award-number":["2023YFA1800804"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB0830402"],"award-info":[{"award-number":["XDB0830402"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270601"],"award-info":[{"award-number":["82270601"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jhepr.2026.101869","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:56:43Z","timestamp":1777046203000},"page":"101869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["ANXA1-FPR1 signaling in myeloid cells drives MASH by elevating S100A4\/A11"],"prefix":"10.1016","volume":"8","author":[{"given":"Siting","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7335-9942","authenticated-orcid":false,"given":"Shengying","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8401-3250","authenticated-orcid":false,"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4473-1089","authenticated-orcid":false,"given":"Yanghuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0111-9399","authenticated-orcid":false,"given":"Shujun","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Ya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0102-977X","authenticated-orcid":false,"given":"Yingfen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4210-007X","authenticated-orcid":false,"given":"Yuanwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8681-5287","authenticated-orcid":false,"given":"Yong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2026.101869_bib1","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.jhep.2023.07.031","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD) definition is better than MAFLD criteria for lean patients with NAFLD","volume":"80","author":"De","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101869_bib2","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101869_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2025-100196","article-title":"Key takeaways from the updated multidisciplinary European MASLD guidelines","volume":"3","author":"Horn","year":"2025","journal-title":"eGastroenterology"},{"key":"10.1016\/j.jhepr.2026.101869_bib4","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.101869_bib5","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/s41423-025-01307-5","article-title":"Immunopathogenic mechanisms and immunoregulatory therapies in MASLD","volume":"22","author":"He","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jhepr.2026.101869_bib6","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101869_bib7","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.livres.2025.01.001","article-title":"New drug therapies for metabolic dysfunction-associated steatohepatitis","volume":"9","author":"Chiang","year":"2025","journal-title":"Liver Res"},{"key":"10.1016\/j.jhepr.2026.101869_bib8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2026.101869_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2023-100020","article-title":"Recent insights into the pathogenesis and therapeutic targets of chronic liver diseases","volume":"1","author":"Wen","year":"2023","journal-title":"eGastroenterology"},{"key":"10.1016\/j.jhepr.2026.101869_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2025-100218","article-title":"Steatotic liver disease and cancer: from pathogenesis to therapeutic targets","volume":"3","author":"Yang","year":"2025","journal-title":"eGastroenterology"},{"key":"10.1016\/j.jhepr.2026.101869_bib11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.livres.2022.05.002","article-title":"Non-alcoholic fatty liver disease development: a multifactorial pathogenic phenomena","volume":"6","author":"Bashir","year":"2022","journal-title":"Liver Res"},{"key":"10.1016\/j.jhepr.2026.101869_bib12","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2026.101869_bib13","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/13543776.2025.2515882","article-title":"Formyl peptide receptor modulators: a patent review and potential applications for inflammatory diseases (2021-2024)","volume":"35","author":"Tsai","year":"2025","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.jhepr.2026.101869_bib14","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.7150\/thno.57218","article-title":"Critical role of FPR1 in splenocyte migration into brain to worsen inflammation and ischemic brain injury in mice","volume":"12","author":"Li","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jhepr.2026.101869_bib15","doi-asserted-by":"crossref","first-page":"eabe9890","DOI":"10.1126\/scitranslmed.abe9890","article-title":"Formyl peptide receptor 1 signaling potentiates inflammatory brain injury","volume":"13","author":"Li","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhepr.2026.101869_bib17","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1161\/CIRCRESAHA.120.317200","article-title":"Dynamics of cardiac neutrophil diversity in murine myocardial infarction","volume":"127","author":"Vafadarnejad","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.jhepr.2026.101869_bib18","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.yexcr.2018.07.016","article-title":"FPR1 gene silencing suppresses cardiomyocyte apoptosis and ventricular remodeling in rats with ischemia\/reperfusion injury through the inhibition of MAPK signaling pathway","volume":"370","author":"Zhou","year":"2018","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jhepr.2026.101869_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155661","article-title":"Hepatocyte-secreted FAM3D ameliorates hepatic steatosis by activating FPR1-hnRNP U-GR-SCAD pathway to enhance lipid oxidation","volume":"146","author":"Hu","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.jhepr.2026.101869_bib20","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/hep.25801","article-title":"Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure","volume":"56","author":"Marques","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.101869_bib21","article-title":"Temporal dichotomy of neutrophil function in acute liver injury and repair","volume":"7","author":"Cartwright","year":"2025","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2026.101869_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2024.103111","article-title":"Protocol to generate human liver spheroids to study liver fibrosis induced by metabolic stress","volume":"5","author":"Kim","year":"2024","journal-title":"STAR Protoc"},{"key":"10.1016\/j.jhepr.2026.101869_bib23","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/HEP.0000000000001405","article-title":"Suppressing MASH fibrotic progression by blocking succinate-GPR91 signaling in HSCs","volume":"83","author":"Xie","year":"2026","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.101869_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911030","article-title":"S100 proteins in fatty liver disease and hepatocellular carcinoma","volume":"23","author":"Delangre","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2026.101869_bib25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41392-024-01797-1","article-title":"METTL14 downregulation drives S100A4(+) monocyte-derived macrophages via MyD88\/NF-kappaB pathway to promote MAFLD progression","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jhepr.2026.101869_bib26","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2337\/db18-1307","article-title":"Microbiota-produced N-formyl peptide fMLF promotes obesity-induced glucose intolerance","volume":"68","author":"Wollam","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.jhepr.2026.101869_bib27","doi-asserted-by":"crossref","first-page":"428","DOI":"10.4049\/jimmunol.173.1.428","article-title":"Identification of neutrophil granule protein cathepsin G as a novel chemotactic agonist for the G protein-coupled formyl peptide receptor","volume":"173","author":"Sun","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jhepr.2026.101869_bib28","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.4049\/jimmunol.174.10.6257","article-title":"Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1\/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant","volume":"174","author":"Kurosaka","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jhepr.2026.101869_bib29","doi-asserted-by":"crossref","first-page":"7669","DOI":"10.4049\/jimmunol.172.12.7669","article-title":"An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family","volume":"172","author":"Ernst","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jhepr.2026.101869_bib30","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/s41467-022-28586-0","article-title":"Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2","volume":"13","author":"Zhuang","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2026.101869_bib31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3390\/molecules22030455","article-title":"The formyl peptide receptors: diversity of ligands and mechanism for recognition","volume":"22","author":"He","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.jhepr.2026.101869_bib32","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125937","article-title":"FPR-1 is an important regulator of neutrophil recruitment and a tissue-specific driver of pulmonary fibrosis","volume":"5","author":"Leslie","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jhepr.2026.101869_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1569927","article-title":"Role of the annexin A protein family in liver diseases: insights and therapeutic opportunities","volume":"16","author":"Feng","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jhepr.2026.101869_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108809","article-title":"Annexin A1 in neurological disorders: neuroprotection and glial modulation","volume":"267","author":"de Souza Ferreira","year":"2025","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2026.101869_bib35","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1182\/blood-2002-11-3411","article-title":"Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms","volume":"101","author":"Gavins","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jhepr.2026.101869_bib36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/CIRCULATIONAHA.118.039345","article-title":"Novel role for the AnxA1-Fpr2\/ALX signaling axis as a key regulator of platelet function to promote resolution of inflammation","volume":"140","author":"Senchenkova","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jhepr.2026.101869_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41423-023-01110-0","article-title":"Glioma-derived ANXA1 suppresses the immune response to TLR3 ligands by promoting an anti-inflammatory tumor microenvironment","volume":"21","author":"Zheng","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jhepr.2026.101869_bib38","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1111\/bph.12768","article-title":"A formyl peptide receptor agonist suppresses inflammation and bone damage in arthritis","volume":"171","author":"Kao","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jhepr.2026.101869_bib39","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1172\/JCI65831","article-title":"Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair","volume":"123","author":"Leoni","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhepr.2026.101869_bib40","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1097\/HEP.0000000000001427","article-title":"Dissecting liver inflammation ecosystem identifies annexin A1 as a pro-resolving target for liver failure","volume":"83","author":"Yu","year":"2026","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.101869_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14232","article-title":"Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice","volume":"8","author":"Qin","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2026.101869_bib42","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2014.07.035","article-title":"S100A4 promotes liver fibrosis via activation of hepatic stellate cells","volume":"62","author":"Chen","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101869_bib43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41392-021-00579-3","article-title":"Exosomal S100A4 derived from highly metastatic hepatocellular carcinoma cells promotes metastasis by activating STAT3","volume":"6","author":"Sun","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jhepr.2026.101869_bib44","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jcmgh.2020.10.006","article-title":"S100A11 promotes liver steatosis via FOXO1-mediated autophagy and lipogenesis","volume":"11","author":"Zhang","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2026.101869_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154725","article-title":"The S100 calcium-binding protein A11 promotes hepatic steatosis through RAGE-mediated AKT-mTOR signaling","volume":"117","author":"Teng","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.jhepr.2026.101869_bib46","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jgg.2022.02.013","article-title":"The S100 calcium binding protein A11 promotes liver fibrogenesis by targeting TGF-beta signaling","volume":"49","author":"Zhu","year":"2022","journal-title":"J Genet Genomics"},{"key":"10.1016\/j.jhepr.2026.101869_bib47","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1136\/gutjnl-2019-319019","article-title":"S100A11\/ANXA2 belongs to a tumour suppressor\/oncogene network deregulated early with steatosis and involved in inflammation and hepatocellular carcinoma development","volume":"69","author":"Sobolewski","year":"2020","journal-title":"Gut"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926001400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926001400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:40:52Z","timestamp":1793148052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555926001400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2589555926001400"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.101869","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ANXA1-FPR1 signaling in myeloid cells drives MASH by elevating S100A4\/A11","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.101869","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101869"}}